Privately held Pennsylvania emerging specialty pharma and biotech therapeutic companies are eligible for help from a new JumpStartGrant announced by Pennsylvania Bio.

The grant can help early stage therapeutic companies raise capital and compete for professional services and expertise in the form of product development and commercialization plans.

“Early stage companies often lack the expertise to comprehensively address the myriad commercial development challenges which exist in the life sciences marketplace,” said Christopher P. Molineaux, president and CEO, Pennsylvania Bio. “We are fortunate to have partnered with two industry leaders on this unique grant opportunity which gives our members access to development and commercialization insights required for preparation of funding applications and presentations.”

Michelle Higgin, of PharmaDirections and Jennifer Filbey, president of New Perspectives, said their organizations are proud to be working with PA Bio to offer this unique opportunity for two of the regions’ most exciting and innovative companies.

“Helping companies with practical solutions to advance their programs and get their products closer to the market and benefiting patients is rewarding for all of us,” said Higgin.

Applications are due no later than Aug. 21, and winners will be announced in October at PA Bio’s Life Sciences Future Signature Event. Interested leadership teams can review application requirements, relevant timelines, and eligibility rules here.

New Perspectives specializes in helping emerging specialty pharma and biotech companies enter the U.S. market to commercialize their assets, whether through a “take-to-market” product launch strategy or a product “license” or acquisition. PharmaDirections, Inc. is a pharmaceutical project management and consulting group focused on CMC (Chemistry, Manufacturing and Controls), formulation development, preclinical and regulatory affairs.

Pennsylvania Bio is the state-wide trade association for the life sciences working to make Pennsylvania a global leader in the life sciences.

_______

Top photo courtesy of  http://www.pabio.org